cDPCP is a DNA crosslinking agent and a substrate for OCT1 and OCT2; it exhibits anticancer activity by improving survival rates in sarcoma-180-bearing mice; it is applicable in the research of colorectal cancer and other cancers expressing appropriate cation transporters.